日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity.

选择性抑制经典 STAT3 信号传导可抑制 K-ras 突变肺肿瘤的发生,并重新激发抗肿瘤免疫力

Clowers Michael J, Rahal Zahraa, Cho Sung-Nam, Krishna Avantika, Yuan Bo, Hamana Zorrilla Leticia G, Eckols T Kris, Kasembeli Moses M, Liu Samuel, Peng Stephen, Ramos-Castaneda Marco, Thompson Annamarie L, Rodriguez Reyna Carlos Ignacio, Larsen Katherine E, Grimaldo Maria T, Deng Shanshan, Karimi Nastaran, Chou Cody, Velasco Walter V, Zarghooni Melody, Alekseev Sayan, Solis Soto Luisa M, Ostrin Edwin J, Kadara Humam, Ekmekcioglu Suhendan, Tweardy David J, Moghaddam Seyed Javad

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy

免疫疗法时代滤泡性甲状腺癌的新兴治疗选择

Turner, Naimah; Hamidi, Sarah; Ouni, Rim; Rico, Rene; Henderson, Ying C; Puche, Maria; Alekseev, Sayan; Colunga-Minutti, Jocelynn G; Zafereo, Mark E; Lai, Stephen Y; Kim, Sang T; Cabanillas, Maria E; Nurieva, Roza

Toxicity in the era of immune checkpoint inhibitor therapy

免疫检查点抑制剂疗法时代的毒性

Keam, Synat; Turner, Naimah; Kugeratski, Fernanda G; Rico, Rene; Colunga-Minutti, Jocelynn; Poojary, Rayansh; Alekseev, Sayan; Patel, Anisha B; Li, Yuanteng Jeff; Sheshadri, Ajay; Loghin, Monica E; Woodman, Karin; Aaroe, Ashley E; Hamidi, Sarah; Iyer, Priyanka Chandrasekhar; Palaskas, Nicolas L; Wang, Yinghong; Nurieva, Roza